Granted Patent
S1
US 1,057,153 · App. 29/836,987 · Granted Jan 7, 2025
Microneedle array sensor applicator device
Assignee:
Biolinq Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Claims (1)
The ornamental design for a microneedle array sensor applicator device, as shown and described.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 26, 2022
From: MORELOCK, DAVID MICHAEL
To: BIOLINQ INCORPORATED
Reel/Frame 061550/0383 →
References Cited (339)
US D178118S
· Enos
· 1956
[cited by applicant]
US D315914S
· Chen
· 1991
[cited by applicant]
US 5137529A
· Watson
· 1992
[cited by examiner]
US D337637S
· Tucker
· 1993
[cited by examiner]
US D345016S
· Stamler
· 1994
[cited by examiner]
US D417732S
· Dagsland
· 1999
[cited by examiner]
US D438794S
· Miles et al.
· 2001
[cited by applicant]
US D444594S
· Angeletta et al.
· 2001
[cited by applicant]
US 6855131B2
· Trautman et al.
· 2005
[cited by applicant]
US 7097631B2
· Trautman et al.
· 2006
[cited by applicant]
US D544298S
· Eide et al.
· 2007
[cited by applicant]
US D574080S
· Segawa
· 2008
[cited by examiner]
US 7582059B2
· Funderburk et al.
· 2009
[cited by applicant]
US D612939S
· Boone, III
· 2010
[cited by examiner]
US D613394S
· Linden
· 2010
[cited by examiner]
US 7946984B2
· Brister et al.
· 2011
[cited by applicant]
US 8094009B2
· Allen et al.
· 2012
[cited by applicant]
US 8125331B2
· Allen et al.
· 2012
[cited by applicant]
US 8130095B2
· Allen et al.
· 2012
[cited by applicant]
US 8175673B2
· Say et al.
· 2012
[cited by applicant]
US D661390S
· McLain
· 2012
[cited by examiner]
US D662122S
· Goodwin
· 2012
[cited by examiner]
US 8252229B2
· Thomas et al.
· 2012
[cited by applicant]
US 8267889B2
· Cantor et al.
· 2012
[cited by applicant]
US 8280475B2
· Brister et al.
· 2012
[cited by applicant]
US 8284046B2
· Allen et al.
· 2012
[cited by applicant]
US D676125S
· Hair
· 2013
[cited by examiner]
US D676126S
· Hair
· 2013
[cited by examiner]
US D681877S
· Curry et al.
· 2013
[cited by applicant]
US 8579862B2
· Kobayashi et al.
· 2013
[cited by applicant]
US 8652043B2
· Drucker et al.
· 2014
[cited by applicant]
US 8753318B2
· Trautman et al.
· 2014
[cited by applicant]
US 8758298B2
· Cantor et al.
· 2014
[cited by applicant]
US 8764657B2
· Curry et al.
· 2014
[cited by applicant]
US 8784363B2
· Frederickson et al.
· 2014
[cited by applicant]
US 8821446B2
· Trautman et al.
· 2014
[cited by applicant]
US D717100S
· Moser et al.
· 2014
[cited by applicant]
US 9008745B2
· Pushpala et al.
· 2015
[cited by applicant]
US 9055901B2
· Brister et al.
· 2015
[cited by applicant]
US 9101305B2
· Larson et al.
· 2015
[cited by applicant]
US 9119945B2
· Simons et al.
· 2015
[cited by applicant]
US D743019S
· Schultz
· 2015
[cited by examiner]
US 9174035B2
· Ringsred et al.
· 2015
[cited by applicant]
US 9215992B2
· Donnay et al.
· 2015
[cited by applicant]
US D750228S
· Strong
· 2016
[cited by examiner]
US D755374S
· Oberlaender
· 2016
[cited by examiner]
US 9357951B2
· Simpson et al.
· 2016
[cited by applicant]
US 9402544B2
· Yee et al.
· 2016
[cited by applicant]
US 9402570B2
· Pace et al.
· 2016
[cited by applicant]
US 9415198B2
· McAllister
· 2016
[cited by applicant]
US 9492647B2
· Stumber et al.
· 2016
[cited by applicant]
US D777903S
· Schultz
· 2017
[cited by examiner]
US 9610401B2
· Antonio et al.
· 2017
[cited by applicant]
US 9615779B2
· Pryor et al.
· 2017
[cited by applicant]
US 9636060B2
· Feldman et al.
· 2017
[cited by applicant]
US 9642568B2
· Shah et al.
· 2017
[cited by applicant]
US 9687640B2
· Trautman et al.
· 2017
[cited by applicant]
US 9717843B2
· Grucela et al.
· 2017
[cited by applicant]
US 9737247B2
· Wang et al.
· 2017
[cited by applicant]
US 9743870B2
· Wang et al.
· 2017
[cited by applicant]
US D797928S
· Davis
· 2017
[cited by examiner]
US 9782574B2
· Simmers
· 2017
[cited by applicant]
US 9789249B2
· Frederickson et al.
· 2017
[cited by applicant]
US 9814414B2
· Brister et al.
· 2017
[cited by applicant]
US D806254S
· Im et al.
· 2017
[cited by applicant]
US 9844328B2
· Simpson et al.
· 2017
[cited by applicant]
US 9933387B1
· McCanna et al.
· 2018
[cited by applicant]
US 9949642B2
· Love et al.
· 2018
[cited by applicant]
US D816836S
· Mueller
· 2018
[cited by examiner]
US 9968742B2
· Van et al.
· 2018
[cited by applicant]
US D827682S
· Anderson
· 2018
[cited by applicant]
US D875254S
· Cooke et al.
· 2020
[cited by applicant]
US D879956S
· Klenner
· 2020
[cited by examiner]
US D883476S
· Lofthouse
· 2020
[cited by examiner]
US D888252S
· Terry
· 2020
[cited by examiner]
US D908204S
· Casiello
· 2021
[cited by examiner]
US D924406S
· Yee et al.
· 2021
[cited by applicant]
US D926326S
· Terry
· 2021
[cited by examiner]
US D928119S
· Walter et al.
· 2021
[cited by applicant]
US D980986S
· Rao et al.
· 2023
[cited by applicant]
US D980993S
· Zhang
· 2023
[cited by examiner]
US D982140S
· Mitrovic
· 2023
[cited by examiner]
US D988160S
· Morelock
· 2023
[cited by applicant]
US D988526S
· Setton
· 2023
[cited by examiner]
US D989331S
· Shen
· 2023
[cited by examiner]
US D996999S
· Morelock
· 2023
[cited by applicant]
US D997362S
· Donnay et al.
· 2023
[cited by applicant]
US D999913S
· Rao
· 2023
[cited by applicant]
US 20020087182A1
· Trautman et al.
· 2002
[cited by applicant]
US 20080242961A1
· Brister et al.
· 2008
[cited by applicant]
US 20100056873A1
· Allen et al.
· 2010
[cited by applicant]
US 20110082484A1
· Saravia et al.
· 2011
[cited by applicant]
US 20110106126A1
· Love et al.
· 2011
[cited by applicant]
US 20110190603A1
· Stafford
· 2011
[cited by applicant]
US 20120303043A1
· Donnay
· 2012
[cited by applicant]
US 20150173661A1
· Myles
· 2015
[cited by applicant]
US 20150351674A1
· Thomas et al.
· 2015
[cited by applicant]
US 20160029931A1
· Salas-Boni et al.
· 2016
[cited by applicant]
US 20180140235A1
· Pushpala et al.
· 2018
[cited by applicant]
US 20190120785A1
· Halac et al.
· 2019
[cited by applicant]
US 20190125223A1
· Wang et al.
· 2019
[cited by applicant]
US 20190239825A1
· Kumar et al.
· 2019
[cited by applicant]
US 20190309433A1
· Sattayasamitsathit et al.
· 2019
[cited by applicant]
US 20200101286A1
· Windmiller et al.
· 2020
[cited by applicant]
US 20200138346A1
· Brister et al.
· 2020
[cited by applicant]
US 20200178853A1
· Pushpala et al.
· 2020
[cited by applicant]
US 20200214566A1
· Allen et al.
· 2020
[cited by applicant]
US 20200254240A1
· Windmiller et al.
· 2020
[cited by applicant]
US 20200297997A1
· Windmiller et al.
· 2020
[cited by applicant]
US 20200360072A1
· Kuang et al.
· 2020
[cited by applicant]
US 20210000399A1
· Curry et al.
· 2021
[cited by applicant]
US 20210076987A1
· Stafford
· 2021
[cited by applicant]
US 20210142912A1
· Belliveau et al.
· 2021
[cited by applicant]
US 20210187286A1
· Windmiller et al.
· 2021
[cited by applicant]
US 20210196162A1
· Halac et al.
· 2021
[cited by applicant]
US 20210219877A1
· Baker et al.
· 2021
[cited by applicant]
US 20210315493A1
· Pace et al.
· 2021
[cited by applicant]
US 20210321914A1
· Brister et al.
· 2021
[cited by applicant]
US 20210321942A1
· Pushpala et al.
· 2021
[cited by applicant]
US 20210379370A1
· Windmiller et al.
· 2021
[cited by applicant]
US 20210393201A1
· Morelock et al.
· 2021
[cited by applicant]
US 20220031244A1
· Windmiller et al.
· 2022
[cited by applicant]
US 20220087610A1
· Pushpala et al.
· 2022
[cited by applicant]
US 20220125344A1
· Pushpala et al.
· 2022
[cited by applicant]
US 20220151516A1
· Wang et al.
· 2022
[cited by applicant]
US 20230137258A1
· Windmiller
· 2023
[cited by applicant]
US 20230301552A1
· Mallires et al.
· 2023
[cited by applicant]
US 20230414102A1
· Allen et al.
· 2023
[cited by applicant]
US 20240081740A1
· Windmiller et al.
· 2024
[cited by applicant]
AU 2015227515B2
· 2017
[cited by applicant]
CN 102307517A
· 2012
[cited by applicant]
CN 107949314A
· 2018
[cited by applicant]
CN 110461217A
· 2019
[cited by applicant]
CN 112294313A
· 2021
[cited by applicant]
CN 112423664A
· 2021
[cited by applicant]
EP 1624913A2
· 2006
[cited by applicant]
EP 2474338A1
· 2012
[cited by applicant]
EP 2532305A1
· 2012
[cited by applicant]
JP 2013524872A
· 2013
[cited by applicant]
JP WO2013035455A1
· 2015
[cited by applicant]
JP 2019507613A
· 2019
[cited by applicant]
JP 2020532326A
· 2020
[cited by applicant]
JP 2021037274A
· 2021
[cited by applicant]
JP 1707722S
· 2022
[cited by applicant]
WO WO2007097754A1
· 2007
[cited by applicant]
WO WO2011119898A1
· 2011
[cited by applicant]
WO WO2013066854A1
· 2013
[cited by applicant]
WO WO2014055456A1
· 2014
[cited by applicant]
WO WO2018071265A1
· 2018
[cited by applicant]
WO WO2019084023A1
· 2019
[cited by applicant]
WO WO2019236859A1
· 2019
[cited by applicant]
WO WO2019236876A1
· 2019
[cited by applicant]
WO WO2020077463A1
· 2020
[cited by applicant]
WO WO2020231405A1
· 2020
[cited by applicant]
WO WO2021101857A1
· 2021
[cited by applicant]
WO WO2021158372A1
· 2021
[cited by applicant]
WO WO2021257624A1
· 2021
[cited by applicant]
WO WO2023055755A1
· 2023
[cited by applicant]
WO WO2023064877A1
· 2023
[cited by applicant]
WO WO2023133468A1
· 2023
[cited by applicant]
WO WO2023229662A2
· 2023
[cited by applicant]
WO WO2024000015A1
· 2024
[cited by applicant]
WO WO2024010827A1
· 2024
[cited by applicant]
WO WO2024163950A2
· 2024
[cited by applicant]
Al Hayek et al., “Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study” Cureus Oct. 27, 2020; 12(10):e11195. 8 p…
[cited by applicant]
Allen et al., “Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial” Diabetes Res Clin Pract. Jun. 2008; 80(3): 371-379. doi:10.1…
[cited by applicant]
Barrett et al., “Risk for Newly Diagnosed Diabetes 30 Days After SARS-CoV-2 Infection Among Persons Aged 18 Years—United States, Mar. 1, 2020-Jun. 28, 2021” MMWR Morb Mortal Wkly Rep. Jan. 14, 2022; 71(2):59-65. doi:10.…
[cited by applicant]
Centers for Disease Control, “National Diabetes Statistics Report 2020 Estimates of Diabetes and Its Burden in the United States” (2020) 32 pages.
[cited by applicant]
Dexcom G7 Sensor, pharmalynk.com, [online], [site visited Sep. 21, 2023], Available from internet, URL: https://store .pharmalynk.com/products/dexcom-g7-cgm (Year: 2023). 1 page.
[cited by applicant]
Dunkin et al., “Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers” Plast Reconstr Surg. May 2007; 119(6):1722-1732. doi: 10.1097/01.prs.0000258829.…
[cited by applicant]
Ehrhardt et al., “Behavior Modification in Prediabetes and Diabetes: Potential Use of Real-Time Continuous Glucose Monitoring” Journal of Diabetes Science and Technology Mar. 2019; 13(2):271-275.
[cited by applicant]
Ehrhardt et al., “Continuous Glucose Monitoring As a Behavior Modification Tool” Clin Diabetes. Apr. 2020; 38(2):126-131. doi: 10.2337/cd19-0037.
[cited by applicant]
Ehrhardt et al., “The Effect of Real-Time Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Mellitus” Journal of Diabetes Science and Technology May 2011; 5(3):668-675.
[cited by applicant]
Fonda et al., “The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes” Journal of Diabetes Science and Technology (2016) 10(4):898-904.
[cited by applicant]
Freestyle Libre 3 Sensor, usmeddirect.com, [online], [site visited Sep. 21, 2023], Available from internet, URL: https:// www.usmeddirect.com/products/freestyle-libre-3-sensor-prescription-required (Year: 2023). 2 pages.
[cited by applicant]
Han et al., “The End of the Road for the YSI 2300 Analyzer: Where Do We Go Now?” Journal of Diabetes Science and Technology (2020) 14(3):595-600.
[cited by applicant]
Han et al., “The YSI 2300 Analyzer Replacement Meeting Report” Journal of Diabetes Science and Technology (2020) 14(3):679-686.
[cited by applicant]
International Search Report and Written Opinion mailed on Mar. 20, 2023, for PCT Application No. PCT/US2022/044950, filed on Sep. 27, 2022, 26 pages.
[cited by applicant]
International Search Report and Written Opinion mailed on May 22, 2023, for PCT Application No. PCT/US2023/060177, filed on Jan. 5, 2023, 20 pages.
[cited by applicant]
Invitation to Pay Additional Fees mailed on Jan. 26, 2023, for PCT Application No. PCT/US2022/044950, filed on Sep. 27, 2022, 22 pages.
[cited by applicant]
Invitation to Pay Additional Fees mailed on Mar. 28, 2023, for PCT Application No. PCT/US2023/060177, filed on Jan. 5, 2023, 15 pages.
[cited by applicant]
Non-Final Office Action mailed on Apr. 25, 2023, for U.S. Appl. No. 17/348,651, filed Jun. 15, 2021, 24 pages.
[cited by applicant]
Non-Final Office Action mailed on Dec. 7, 2022, for U.S. Appl. No. 17/954,289, filed Sep. 27, 2022, 7 pages.
[cited by applicant]
Non-Final Office Action mailed on Sep. 8, 2023, for U.S. Appl. No. 18/139,308, filed Apr. 25, 2023, 7 pages.
[cited by applicant]
Notice of Allowance mailed on Jan. 3, 2023, for U.S. Appl. No. 17/954,293, filed Sep. 27, 2022, 8 pages.
[cited by applicant]
Notice of Allowance mailed on Jan. 26, 2023, for U.S. Appl. No. 17/954,289, filed Sep. 27, 2022, 9 pages.
[cited by applicant]
Notice of Allowance mailed on Sep. 12, 2023, for U.S. Appl. No. 18/139,302, filed Apr. 25, 2023, 8 pages.
[cited by applicant]
Sharifi et al., “Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring” Journal of Diabetes Science and Technology (2016) 10(3):669-678.
[cited by applicant]
Turner et al., “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)” The Lancet Sep. 1998; 352(9131):…
[cited by applicant]
Vigersky et al., “Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients with Type 2 Diabetes” Diabetes Care Jan. 2012; 35:32-38.
[cited by applicant]
Wolicki et al., “Epidemiology and Prevention of Vaccine-Preventable Diseases: Chapter 6: Vaccine Administration” Centers for Disease Control and Prevention (2021) 17 pages.
[cited by applicant]
World Health Organization, “Diabetes”, Sep. 16, 2022, 5 pages.
[cited by applicant]
Written Opinion (Second Opinion) of the International Preliminary Examining Authority mailed on May 25, 2023, for PCT Application No. PCT/US2022/044950, filed on Sep. 27, 2022, 14 pages.
[cited by applicant]
Young et al., “Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial” Jama Intern Med. Jul. 2017; 177(7):920-929.
[cited by applicant]
Abbot press release (2020). “New late-breaking data show use of Abbott's Freestyle® Libre System significantly reduces HBA1C levels in people with type 2 diabetes using insulin or not,” 3 pages.
[cited by applicant]
American Diabetes Association® Press Release (2020). “American Diabetes Association ® Applauds policymakers' Focus on Addressing High Costs of Insulin for Seven Million Americans,” 4 pages.
[cited by applicant]
Bantle, J.P. et al. (1997). “Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid,” J. Lab. Clin. Med. 130:436-441.
[cited by applicant]
Beckles, G.L. et al. (2016). “Disparities in the prevalence of diagnosed diabetes—United States, 1999-2002 and 2011-2014,” MMWR 65:1265-1269.
[cited by applicant]
Cao, J. et al. (2017). “Validation of capillary blood analysis and capillary testing mode on the epoc Point of Care system,” Pract. Lab. Med. 9:24-27.
[cited by applicant]
Castle, J.R. et al. (2012). “The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes,” Diabetes Care 35:706-710.
[cited by applicant]
Dexcom (2020). Analyst Day Presentation, 19 total pages.
[cited by applicant]
Dexcom (2020). Analyst Day Presentation, 27 total pages.
[cited by applicant]
Diabetes Care (2021). “7. Diabetes Technology: Standards of Medical Care in Diabetes—2021,” Diabetes Care 44(Supplement 1):S85-S99.
[cited by applicant]
Fang, M. et al. (2021). “Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018,” Engl. Med. 384:2219-2228.
[cited by applicant]
French, D.P. et al. (2008). “Original Article: Psychological Care Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial,”…
[cited by applicant]
Grady, M. et al. (2017). “Examining the Impact of a Novel Blood Glucose Monitor with Color Range indicator on Decision-Making in Patients With Type 1 and Type 2 Diabetes and its Association With Patient Numeracy Level,”…
[cited by applicant]
Grady, M. et al. (2018). “Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients with Diabetes in Comparison to Blood Glucose Meters Without Color (Accents Study),” J. Diab. S…
[cited by applicant]
Groenendaal, W. et al. (2008). “Modeling Glucose and Water Dynamics in Human Skin,” Diab. Tech. Therap. 10:283-293.
[cited by applicant]
International Search Report mailed on Sep. 9, 2021, for PCT Application No. PCT/US2021/037511, filed on Jun. 15, 2021, 2 pages.
[cited by applicant]
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008). “Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes,” N. Engl. Med. 359:1464-1476.
[cited by applicant]
Karter, A.J. et al. (2021). “Association of Real-time Continuous Glucose Monitoring with Glycemic Control and Acute Metabolic Events Among Patients with Insulin-Treated Diabetes,” Jama 325:2273-2284.
[cited by applicant]
Martens, T. et al. (2021). “Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin a Randomized Clinical Trial,” Jama 325:2262-2272.
[cited by applicant]
McClatchey, P.M. et al. (2019). “Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays,” Diabetes 68:1892-1901.
[cited by applicant]
Neerken, S. et al. (2004). “Characterization of age-related effects in human skin: A comparative study that applies confocal laser scanning microscopy and optical coherence tomography,” J. Blomed. Optics 9:274-281.
[cited by applicant]
Polonsky, W.H. et al. (2011). “A survey of blood glucose monitoring in patients with type 2 diabetes: Are recommendations from health care professionals being followed?” Curr. Med. Res. & Opinion 27:31-37.
[cited by applicant]
Rigla, M. et al. (2018). “Human Subcutaneous Tissue Response to Glucose Sensors: Macrophages Accumulation Impact on Sensor Accuracy,” Diabetes Technology & Therapeutics 20:296-302.
[cited by applicant]
Sheikh, Z. et al. (2015). “Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials,” Materials 8:5671-5701.
[cited by applicant]
Shi, T. et al. (2016). “Modeling and Measurement of Correlation between Blood and Interstitial Glucose Changes,” J. Diab. Res. vol. 2016, 9 pages.
[cited by applicant]
Written Opinion of the International Searching Authority mailed on Sep. 9, 2021, for PCT Application No. PCT/US2021/037511, filed on Jun. 15, 2021, 6 pages.
[cited by applicant]
American Diabetes Association, “Diabetes and Emotional Health: A Practical Guide for Health Professionals Supporting Adults with Type 1 and Type 2 Diabetes” U.S. Edition (2021), 214 pages.
[cited by applicant]
American Diabetes Association Professional Practice Committee, “6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024” Diabetes Care Jan. 1, 2024; 47(Suppl 1):S111-S125.
[cited by applicant]
American Diabetes Association Professional Practice Committee, “7. Diabetes Technology: Standards of Medical Care in Diabetes-2022” Diabetes Care Jan. 1, 2022; 45(Suppl 1):S97-S112.
[cited by applicant]
Centers for Disease Control, “National Diabetes Statistics Report” May 2024, 16 pages.
[cited by applicant]
Communication pursuant to Rule 164(2)(b) and Article 94(3) EPC mailed on Mar. 22, 2024, for EP Application No. 22793312.4, 10 pages.
[cited by applicant]
Diabetes Control and Complications Trial Research Group, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus” N Engl J Med …
[cited by applicant]
Elsayed et al., “2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023” Diabetes Care Jan. 1, 2023; 46(Suppl 1):S19-S40.
[cited by applicant]
Ex Parte Quayle Action mailed on Jan. 16, 2024, for U.S. Appl. No. 29/819,952, filed Dec. 17, 2021, 6 pages.
[cited by applicant]
Extended European Search Report for European Application No. EP21827162.5 dated Jun. 4, 2024, 10 pages.
[cited by applicant]
Final Office Action for U.S. Appl. No. 17/348,651 dated Feb. 16, 2024, 22 pages.
[cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2024/029703 dated Aug. 8, 2024, 21 pages.
[cited by applicant]
Mendes-Soares et al., “Assessment of a Personalized Approach to Predicting Postprandial Glycemic Responses to Food Among Individuals Without Diabetes” Jama Network Open Feb. 1, 2019; 2(2):e188102. 13 pages.
[cited by applicant]
Miller et al., “Hypoglycemia in patients with type 2 diabetes mellitus” Arch Intern Med Jul. 9, 2001; 161(13):1653-1659.
[cited by applicant]
Newton et al., “Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences” Arch Intern Med Sep. 27, 2004; 164(17):1925-1931.
[cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/139,302 dated Dec. 20, 2023, 5 pages.
[cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/139,308 dated Apr. 3, 2024, 2 pages.
[cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/139,308 dated Dec. 22, 2023, 7 pages.
[cited by applicant]
Notice of Allowance for U.S. Appl. No. 29/819,952 dated Mar. 6, 2024, 5 pages.
[cited by applicant]
Segel et al., “Hypoglycemia-associated autonomic failure in advanced type 2 diabetes” Diabetes Mar. 202; 51(3):724-733.
[cited by applicant]
Shivers et al., “Turn it off!: diabetes device alarm fatigue considerations for the present and the future” J Diabetes Sci Technol May 1, 2013; 7(3):789-794.
[cited by applicant]
Tanenbaum et al., “Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets” Diabetes Care Feb. 2017; 40(2):181-187.
[cited by applicant]
UK Prospective Diabetes Study (UKPDS) Group, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)” La…
[cited by applicant]